News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
February, 2025
February 2025
M T W T F S S
 12
3456789
10111213141516
17181920212223
2425262728  
Yüksel Ürün: MFS continues to be a reliable predictor for overall survival
Photo from Yüksel Ürün/X
Dec 10, 2023, 16:59

Yüksel Ürün: MFS continues to be a reliable predictor for overall survival

Yüksel Ürün, Medical Oncologist at Ankara University, shared on X:

“With better access to docetaxel and other treatments for advanced prostate cancer, MFS continues to be a reliable predictor for overall survival. This reinforces MFS’s role as the main outcome for current adjuvant trials in localized prostate cancer, impacting future trial designs.”

For more details click here.
Source: Yüksel Ürün/X

access to treatment adjuvant trials advanced disease cancer docetaxel localized disease MFS OncoDaily Oncology overall survival prostate cancer trial designs Yüksel Ürün
Special Coverage
Celebrities
Feb 22, 2025, 11:40
Remembering Saxophonist James Casey: His Battle with Colon Cancer and Advocacy
Career
Feb 22, 2025, 11:36
Joseph H. Antin Received ASTCT Lifetime Achievement Award at 2025 Tandem Meetings
Science
Feb 22, 2025, 11:28
Myeloma Paper of the Day, February 22nd, suggested by Robert Orlowski
Blog
Feb 22, 2025, 11:22
Yan Leyfman: Great experience speaking at the NSHSS Pre-Medicine Workshop
Insight
Feb 22, 2025, 11:15
Henrik Ullum: The urgent need to protect WHO is also an opportunity
Oncolibrary
Feb 22, 2025, 11:02
New Paper Alert: Efficacy of Zenocutuzumab in NRG1 Fusion–Positive Cancer
Blog
Feb 22, 2025, 10:57
Tsetsegsaikhan Batmunkh: Factsheets for parents on childhood cancers and essential medicines in the Mongolian
Blog
Feb 22, 2025, 10:47
Akhilesh Bind: Advancing political leadership for equitable cancer care
Blog
Feb 22, 2025, 10:41
Nominations close for the 2025 Szent-Györgyi Prize for Progress in Cancer Research - NFCR
Blog
Feb 22, 2025, 06:28
Michael Sapienza: Breaking the stigma associated with CRC screening with Lead From Behind
Blog
Feb 22, 2025, 05:23
Sanam Loghavi: Excited to see the draft agenda for the inaugural Women in Hematology meeting
Blog
Feb 22, 2025, 05:18
Francisco J. Esteva: The clinical applications of PARPi across various cancers